World's Best Scientists 2026 revealed!
VIEW LIST
Paolo A. Ascierto

D-Index & Metrics

Medicine

D-Index
123
Citations
109527
World Ranking
3258
National Ranking
1797

Paolo A. Ascierto publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paolo A. Ascierto sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 915 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paolo A. Ascierto D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paolo A. Ascierto sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 123 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paolo A. Ascierto is affiliated with the National Institutes of Health in the United States and has contributed extensively to the field of oncology, with a focus on cancer immunotherapy and melanoma research. Their work spans various subfields, including oncology, molecular biology, immunology, epidemiology, and infectious diseases.

The scientist's research covers several key topics, such as:

  • Cancer Immunotherapy and Biomarkers
  • Melanoma and MAPK Pathways
  • CAR-T Cell Therapy Research
  • Cutaneous Melanoma Detection and Management
  • Immunotherapy and Immune Responses
  • Colorectal Cancer Treatments and Studies
  • Nonmelanoma Skin Cancer Studies

Frequent publication venues for Paolo A. Ascierto include:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • European Journal of Cancer
  • Journal for ImmunoTherapy of Cancer
  • Journal of Translational Medicine

Frequent coauthors collaborating with Paolo A. Ascierto include:

  • Georgina V. Long
  • Dirk Schadendorf
  • Caroline Robert
  • Piotr Rutkowski
  • Reinhard Dummer

Among their recent papers are:

  • "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events" (2021), Journal for ImmunoTherapy of Cancer
  • "Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial" (2020), The Lancet
  • "Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma" (2022), Zurich Open Repository and Archive (University of Zurich)
  • "Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial" (2020), The Lancet Oncology
  • "Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer" (2020), Nature Communications

Paolo A. Ascierto's extensive publication record reflects a concentration on immune checkpoint inhibitors, melanoma treatment strategies, and immunotherapy response mechanisms. Their research integrates clinical trials and biomolecular investigations to advance understanding and treatment of advanced cancers.

Best Publications

  • Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

    Paul B. Chapman;Axel Hauschild;Caroline Robert;John B. Haanen

  • Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

    James Larkin;Vanna Chiarion-Sileni;Rene Gonzalez;Jean Jacques Grob

  • Nivolumab in previously untreated melanoma without BRAF mutation.

    Caroline Robert;Georgina V. Long;Benjamin Brady;Caroline Dutriaux

  • Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

    Jedd D. Wolchok;Vanna Chiarion-Sileni;Rene Gonzalez;Piotr Rutkowski

  • Five-year survival with combined nivolumab and ipilimumab in advanced melanoma: New England Journal of Medicine

    J. Larkin;V. Chiarion-Sileni;R. Gonzalez;J.-J. Grob

  • Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

    Jeffrey S Weber;Sandra P D'Angelo;David Minor;F Stephen Hodi

  • Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.

    Aurelien Marabelle;Dung T. Le;Paolo A. Ascierto;Anna Maria Di Giacomo

  • Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma

    James Larkin;Paolo A. Ascierto;Brigitte Dréno;Victoria Atkinson

  • Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

    Jeffrey Weber;Mario Mandala;Michele Del Vecchio;Helen J. Gogas

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

    Alexander M.M. Eggermont;Christian U. Blank;Mario Mandala;Georgina V. Long

  • Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

    Antoni Ribas;Igor Puzanov;Reinhard Dummer;Dirk Schadendorf

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

    Alexander M M Eggermont;Vanna Chiarion-Sileni;Jean-Jacques Grob;Reinhard Dummer

  • Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

    Scott J. Antonia;José A. López-Martin;Johanna Bendell;Patrick A. Ott

  • Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

    Alexander M M Eggermont;Vanna Chiarion-Sileni;Jean Jacques Grob;Reinhard Dummer

  • Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

    Grant A McArthur;Paul B Chapman;Caroline Robert;James Larkin

  • Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial.

    Paolo A Ascierto;Grant A McArthur;Grant A McArthur;Brigitte Dréno;Victoria Atkinson

  • Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

    Georgina V. Long;Uwe Trefzer;Michael A. Davies;Richard F. Kefford

  • Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial

    Reinhard Dummer;Paolo A Ascierto;Helen J Gogas;Ana Arance

Frequent Co-Authors

Gerardo Botti
Gerardo Botti Istituto Giannina Gaslini
Giuseppe Palmieri
Giuseppe Palmieri National Academies of Sciences, Engineering, and Medicine
Dirk Schadendorf
Dirk Schadendorf University of Duisburg-Essen
Caroline Robert
Caroline Robert University of Paris-Saclay
Georgina V. Long
Georgina V. Long University of Sydney
Michele Maio
Michele Maio University of Siena
Reinhard Dummer
Reinhard Dummer University of Zurich
James Larkin
James Larkin Royal Marsden NHS Foundation Trust
Claus Garbe
Claus Garbe University of Tübingen
Mario Mandalà
Mario Mandalà European Institute of Oncology

External Links

Personal website of Paolo A. Ascierto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of Medicine in the USA doesn’t just mean becoming a doctor. There are a growing number of rewarding roles and degree programs that offer diverse career pathways. Many students are choosing online options, which often provide greater flexibility and cost savings.

Careers in hospital management and operational leadership are in high demand. You can start by pursuing healthcare administration degrees online, making it easier to study while gaining hands-on experience. For those aiming for advanced roles, there are cheapest mha programs that offer solid preparation for upper management in healthcare facilities.

Nursing professionals looking to enhance their expertise and impact might consider cheap online dnp programs, which open doors to leadership, research, and academic positions. Alternatively, those interested in pharmaceutical sciences can earn advanced credentials through online pharmd programs, expanding their scope to include clinical, consulting, and industry roles.

Online degrees in these areas can help you prepare for a meaningful career in healthcare, often at a lower price and with more flexible scheduling than traditional on-campus programs.

Best Scientists Citing Paolo A. Ascierto

Georgina V. Long

Georgina V. Long

University of Sydney

Publications: 283

Richard A. Scolyer

Richard A. Scolyer

Royal Prince Alfred Hospital

Publications: 219

Dirk Schadendorf

Dirk Schadendorf

University of Duisburg-Essen

Publications: 176

Keith T. Flaherty

Keith T. Flaherty

Harvard University

Publications: 167

Alexander M. Menzies

Alexander M. Menzies

University of Sydney

Publications: 165

Caroline Robert

Caroline Robert

University of Paris-Saclay

Publications: 159

Jedd D. Wolchok

Jedd D. Wolchok

Cornell University

Publications: 158

Richard F. Kefford

Richard F. Kefford

Macquarie University

Publications: 155

John F. Thompson

John F. Thompson

University of Sydney

Publications: 151

Michael A. Postow

Michael A. Postow

Memorial Sloan Kettering Cancer Center

Publications: 139

Reinhard Dummer

Reinhard Dummer

University of Zurich

Publications: 139

Douglas B. Johnson

Douglas B. Johnson

Vanderbilt University Medical Center

Publications: 135

Antoni Ribas

Antoni Ribas

University of California, Los Angeles

Publications: 133

F. Stephen Hodi

F. Stephen Hodi

Harvard University

Publications: 130

Grant A. McArthur

Grant A. McArthur

Peter MacCallum Cancer Centre

Publications: 123

James Larkin

James Larkin

Royal Marsden NHS Foundation Trust

Publications: 122

Trending Scientists

Martin Bohus

Martin Bohus

Central Institute of Mental Health

Maria Densmore

Maria Densmore

University of Western Ontario

Rongqing Zhang

Rongqing Zhang

Nanjing University

David S. Park

David S. Park

New York University

Michael L. Evans

Michael L. Evans

The Ohio State University

Christine S. Falk

Christine S. Falk

Hannover Medical School

Zihai Li

Zihai Li

The Ohio State University

Suizheng Qiu

Suizheng Qiu

Xi'an Jiaotong University

Philippe Grelu

Philippe Grelu

University of Burgundy

Peter Reinartz

Peter Reinartz

German Aerospace Center

Jeremie Leguay

Jeremie Leguay

Huawei Technologies (China)

Robin K. Harris

Robin K. Harris

Durham University

Alfred Hassner

Alfred Hassner

Bar-Ilan University

Laurence Slutsker

Laurence Slutsker

Centers for Disease Control and Prevention

Paul W. Leadley

Paul W. Leadley

University of Paris-Saclay

Mahmoud Shakeri

Mahmoud Shakeri

Amirkabir University of Technology

Related Medicine Rankings & Guides

2026 Best Paramedic-to-RN Bridge Programs

2026 Best Paramedic-to-RN Bridge Programs
2026 Most Affordable Online DNP Programs

2026 Most Affordable Online DNP Programs
2026 Most Affordable Online Accelerated BSN Programs for Non-Nurses

2026 Most Affordable Online Accelerated BSN Programs for Non-Nurses
2026 Best Pathways to Pursue MSN without a BSN Degree

2026 Best Pathways to Pursue MSN without a BSN Degree
August 2026 Best Online Certificate Programs in Medical Billing & Coding Programs

August 2026 Best Online Certificate Programs in Medical Billing & Coding Programs
2026 Best Nurse Practitioner Programs in North Carolina – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in North Carolina – Accredited Schools Online & Campus
2026 Easiest Nurse Midwife Programs to Get Into

2026 Easiest Nurse Midwife Programs to Get Into
2026 Easiest Nurse Practitioner Specialty Programs to Get Into

2026 Easiest Nurse Practitioner Specialty Programs to Get Into
2026 Best Online Dual FNP/PMHNP Degree Programs

2026 Best Online Dual FNP/PMHNP Degree Programs
2026 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus

2026 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus
2026 Is Nursing School Worth It?

2026 Is Nursing School Worth It?
2026 Most Affordable Online MSN in Nurse Executive Leadership Programs

2026 Most Affordable Online MSN in Nurse Executive Leadership Programs
2026 Fastest Online MSN in Nursing Education Programs

2026 Fastest Online MSN in Nursing Education Programs
2026 Best Online MSN Family Nurse Practitioner Programs

2026 Best Online MSN Family Nurse Practitioner Programs
2026 Most Affordable LVN to RN Online Bridge Programs

2026 Most Affordable LVN to RN Online Bridge Programs
2026 Best Online Medical Assistant Associate Degree Programs

2026 Best Online Medical Assistant Associate Degree Programs
2026 Medical Billing and Coding Certificate vs. Bachelor's Degree: Explaining the Difference

2026 Medical Billing and Coding Certificate vs. Bachelor's Degree: Explaining the Difference
2026 Best Online Bachelor’s Degrees in Nutritional Science Programs

2026 Best Online Bachelor’s Degrees in Nutritional Science Programs
2026 Best Online Associate in Physical Therapy Assistant Programs

2026 Best Online Associate in Physical Therapy Assistant Programs
2026 Best Shortest Online DNP Programs

2026 Best Shortest Online DNP Programs
2026 Best Online MSN in Forensic Nursing Programs

2026 Best Online MSN in Forensic Nursing Programs

Recently Published Articles

2026 How Fast Can You Get a Marriage & Family Counseling Degree Online?

2026 How Fast Can You Get a Marriage & Family Counseling Degree Online?
2026 Best Online Bachelor’s Degrees in Theology Programs

2026 Best Online Bachelor’s Degrees in Theology Programs
2026 How to Become an Echocardiogram Technician: Education, Salary, and Job Outlook

2026 How to Become an Echocardiogram Technician: Education, Salary, and Job Outlook
2026 Cheapest and Shortest Online Animal Science Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2026 Cheapest and Shortest Online Animal Science Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2026 Easiest MBA Programs to Get Into

2026 Easiest MBA Programs to Get Into
2026 Best Online Marketing Degree Programs

2026 Best Online Marketing Degree Programs
2026 Fastest Online Bachelor's in Mathematics Degree Programs

2026 Fastest Online Bachelor's in Mathematics Degree Programs
2026 Online Sports Psychology Degree Programs Costs: Tuition & Fees

2026 Online Sports Psychology Degree Programs Costs: Tuition & Fees
2026 How Long Does It Take to Earn an Online Teaching Degree?

2026 How Long Does It Take to Earn an Online Teaching Degree?
2026 Best Organizational Leadership Degree Programs in California: Online & Campus

2026 Best Organizational Leadership Degree Programs in California: Online & Campus
2026 Best Medical Assistant to LPN Programs Online

2026 Best Medical Assistant to LPN Programs Online
2026 Cheapest Online Environmental Engineering Bachelor's Degrees That Pay Well: Tuition, Duration, and Earnings

2026 Cheapest Online Environmental Engineering Bachelor's Degrees That Pay Well: Tuition, Duration, and Earnings
2026 Addiction Counseling vs. Psychology Degree Programs: Explaining The Difference

2026 Addiction Counseling vs. Psychology Degree Programs: Explaining The Difference
2026 Easiest Pharmacy Schools to Get Into

2026 Easiest Pharmacy Schools to Get Into
2026 Online Mechanical Engineering Bachelor's Degree Programs That Accept Transfer Credits

2026 Online Mechanical Engineering Bachelor's Degree Programs That Accept Transfer Credits
2026 Best LPN Programs in Michigan – Accredited Online LPN Programs

2026 Best LPN Programs in Michigan – Accredited Online LPN Programs
2026 Best BSN to DNP Programs in Texas: Online & Campus

2026 Best BSN to DNP Programs in Texas: Online & Campus
2026 What Can You Do With a Master of Fine Arts (MFA) Degree?

2026 What Can You Do With a Master of Fine Arts (MFA) Degree?
2026 What Degree Do You Need to Be a Social Worker: Education Requirements in Louisiana

2026 What Degree Do You Need to Be a Social Worker: Education Requirements in Louisiana
2026 Child Counselor Careers: Guide to Career Paths, Options & Salary

2026 Child Counselor Careers: Guide to Career Paths, Options & Salary
2026 Military-Friendly Online Public Health Master's Degree Programs: Benefits, Accreditation & Career Outcomes

2026 Military-Friendly Online Public Health Master's Degree Programs: Benefits, Accreditation & Career Outcomes